The Vanderbilt-Ingram Cancer Center (VICC) is an NCI-designated clinical cancer center and has, as a core mission. Increased recruitment of cancer patients into NCI-approved studies. To facilitate this activity, a Clinical Trials Shared Resource (CTSR) was created. The CTSR allows VICC investigators to carry out investigator-initiated clinical studies. In addition, the VICC has a well-established research network of community hospitals through the VICC Affiliate Network. While the demographic representation of VICC study participants mirrors that of the state of Tennessee, the MMC/VICC Partnership is committed to further improving minority cancer patient participation in clinical trials. The resources required to carry out this goal are considerable but are made available, in part, through the VICC's Cancer Center Support Grant (CCSG). We propose to expand the resources of the VICC CTSR to assist Meharry investigators in their efforts to increase accrual. In addition, there is a real need to increase the Meharry clinical trials infrastructure to permit broad participation in clinical trials at Meharry hospital and affiliated clinics. To assume the additional workload generated by recruitment of patients from MMC and its affiliated clinics requires research staff. At a minimum, we anticipate one fully trained data manager and one fully trained research nurse are needed to staff a satellite office at MMC. A Clinical Trials Program Coordinator and a CTSR Research Nurse are needed to assist in the hiring, training, and mentoring of the MMC staff.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Specialized Center--Cooperative Agreements (U54)
Project #
5U54CA091405-02
Application #
6662115
Study Section
Special Emphasis Panel (ZCA1)
Project Start
2002-09-20
Project End
2003-04-30
Budget Start
Budget End
Support Year
2
Fiscal Year
2002
Total Cost
Indirect Cost
Name
Vanderbilt University Medical Center
Department
Type
DUNS #
004413456
City
Nashville
State
TN
Country
United States
Zip Code
37203
Nichols, Erin E; Richmond, Ann; Daniels, Anthony B (2016) Tumor Characteristics, Genetics, Management, and the Risk of Metastasis in Uveal Melanoma. Semin Ophthalmol 31:304-9
Vaiopoulou, Anna; Gazouli, Maria; Papadopoulou, Aggeliki et al. (2015) Serum protein profiling of adults and children with Crohn disease. J Pediatr Gastroenterol Nutr 60:42-7
Ning, Matthew S; Kim, Annette S; Prasad, Nripesh et al. (2014) Characterization of the Merkel Cell Carcinoma miRNome. J Skin Cancer 2014:289548
Seeley, Erin H; Washington, Mary K; Caprioli, Richard M et al. (2013) Proteomic patterns of colonic mucosal tissues delineate Crohn's colitis and ulcerative colitis. Proteomics Clin Appl 7:541-9
M'Koma, Amosy E (2013) Letter to Editor. Adv Enzyme Res 1:77-78
Ochieng, Josiah; Chaudhuri, Gautam (2010) Cystatin superfamily. J Health Care Poor Underserved 21:51-70
Mittal, Mukul K; Myers, Jeremy N; Bailey, Charvann K et al. (2010) Mode of action of the retrogene product SNAI1P, a SNAIL homolog, in human breast cancer cells. Mol Biol Rep 37:1221-7
Zheng, Wei; Cai, Qiuyin; Signorello, Lisa B et al. (2009) Evaluation of 11 breast cancer susceptibility loci in African-American women. Cancer Epidemiol Biomarkers Prev 18:2761-4
Daikoku, Takiko; Hirota, Yasushi; Tranguch, Susanne et al. (2008) Conditional loss of uterine Pten unfailingly and rapidly induces endometrial cancer in mice. Cancer Res 68:5619-27
Daikoku, Takiko; Tranguch, Susanne; Chakrabarty, Anindita et al. (2007) Extracellular signal-regulated kinase is a target of cyclooxygenase-1-peroxisome proliferator-activated receptor-delta signaling in epithelial ovarian cancer. Cancer Res 67:5285-92

Showing the most recent 10 out of 11 publications